Company Filing History:
Years Active: 2006
Title: The Innovations of Pierre-André Trinel
Introduction
Pierre-André Trinel, an accomplished inventor based in Villeneuve d'Ascq, France, has made significant contributions to the pharmaceutical field. With a focus on synthetic oligomannosides, his work aims to enhance therapeutic approaches in combating infectious organisms and pathogens.
Latest Patents
Trinel holds a notable patent titled "Synthetic oligomannosides, preparation and uses thereof." This innovative patent details a pharmaceutical composition that incorporates a therapeutically effective amount of at least one oligomannoside, which is produced through chemical synthesis. This oligomannoside is homologous to a wall oligomannoside found in infectious organisms, or includes derivatives thereof, combined with a pharmaceutically acceptable vehicle.
Career Highlights
Pierre-André Trinel is affiliated with the Centre Hospitalier Régional Universitaire (CHRU), where he engages in research aimed at developing advanced pharmaceutical solutions. His commitment to innovation and excellence is reflected in his single patent, which showcases his potential impact on the medical community.
Collaborations
Throughout his career, Trinel has collaborated with esteemed colleagues, including Jacques Esnault and Pierre Sinay. These partnerships highlight the collaborative spirit in research, contributing to advancements in their field and fostering innovation.
Conclusion
Pierre-André Trinel remains a pivotal figure in the realm of pharmaceutical innovations. His patent on synthetic oligomannosides exemplifies the intersection of chemistry and therapeutics, showcasing his dedication to improving health outcomes. The partnerships he has built further emphasize the importance of collaboration in scientific innovation, positioning him as a key player in the ongoing fight against infectious diseases.